Search

Issue
Title
Authors
Histological remission of ulcerative colitis with combined anti-cytokine and cell therapy
Knyazev O.V., Khomeriki S.G., Kagramanova A.V., Lishchinskaya A.A., Smirnova O.A., Noskova K.K., Parfenov A.I.
Frequency and risk factors for thromboembolic complications in patients with inflammatory bowel diseases
Lishchinskaya A.A., Knyazev O.V., Kagramanova A.V., Dudina G.A., Sabelnikova E.A., Li I.A., Noskova K.K., Bodunova N.A., Parfenov A.I.
Ulcerative colitis. To the 180th anniversary of the description by Karl Rokytansky
Knyazev O.V., Kagramanova A.V., Parfenov A.I.
Low adherence to treatment is a weak link in the problems of ulcerative colitis
Parfenov A.I., Knyazev O.V., Babayan A.F., Kagramanova A.V.
Pharmacological and clinical feature of rebamipide: new therapeutic targets
Zvyaglova M.Y., Knyazev O.V., Parfenov A.I.
The cardiovascular system in patients with functional and inflammatory bowel diseases
Maev I.V., Kazulin A.N., Andreev D.N.
Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management
Bakulin I.G., Skalinskaya M.I., Maev I.V., Skazyvaeva E.V., Zhuravleva M.S., Gaikovaya L.B., Bakulina N.V., Ermakov A.I., Alekseenko E.S., Ivanova K.N., Solovev M.V.
Evaluation of efficacy and comparative frequency of adverse events in patients with ulcerative colitis receiving the original infliximab and its biosimilar. One year of observation
Knyazev O.V., Shkurko T.V., Kagramanova A.V., Lishchinskaya A.A., Zvyaglova M.Y., Korneeva I.A., Babayan A.F., Parfenov A.I.
Ultrasound examination with contrast in the diagnosis of inflammatory bowel disease. The results of the pilot study
Fomin V.V., Ternovoy S.K., Makhov V.M., Isaykina M.A., Dzhenzhera N.A., Turko T.V., Ugryumova L.N., Babenko O.V.
Immune response to biological therapy for inflammatory bowel diseases
Kniazev O.V., Parfenov A.I., Ruchkina I.N., Lazebnik L.B., Sagynbaeva V.É.
USE of allogeneic mesenchymal stem cells in the treatment of intestinal inflammatory diseases
Lazebnik L.B., Konoplyannikov A.G., Knyazev O.V., Parfenov A.I., Tsaregorodtseva T.M., Ruchkina I.N., Khomeriki S.G., Rogozina V.A., Konoplyannikova O.A., Lazebnik L.B., Konoplyannikov A.G., Knyazev O.V., Parfenov A.I., Tsaregorodtseva T.M., Ruchkina I.N., Khomeriki S.G., Rogozina V.A., Konoplyannikova O.A.
Clinical value of antibodies in inflammatory bowel diseases
Aleksandrova E.N., Novikov A.A., Lukina G.V., Parfenov A.I.
O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova, S.V. Belousov, A.I. Parfenov
Knyazev O.V., Kagramanova A.V., Korneeva I.A., Noskova K.K., Belousov S.V., Parfenov A.I.
Personalized medicine in the treatment of inflammatory bowel diseases
Parfenov A.I., Knyazev O.V., Kagramanova A.V., Fadeeva N.A.
Lung disease/pneumonitis in a patient with ulcerative colitis due to mesalazine
Sablin O.A., Chernousova V.V., Komlev A.D.
Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease
Danilova N.A., Abdulkhakov S.R., Grigoryeva T.V., Markelova M.I., Vasilyev I.Y., Boulygina E.A., Ardatskaya M.D., Pavlenko A.V., Tyakht A.V., Odintsova A.K., Abdulkhakov R.A.
Long-term infliximab therapy for ulcerative colitis in real clinical practice
Knyazev O.V., Parfenov A.I., Kagramanova A.V., Ruchkina I.N., Shcherbakov P.L., Shakhpazyan N.K., Noskova K.K., Ivkina T.I., Khomeriki S.G.
A new system of specialized gastroenterological care to patients with inflammatory bowel diseases in Saint Petersburg
Baranovskiĭ A.I., Kondrashina É.A., Segal' A.M.
Policy of pharmacological treatment of ulcerative colitis (a review of foreign literature)
Rumyanlsev V.G.
Loss of response and frequency of adverse events in patients with ulcerative colitis and Crohn’s disease when switching from the original infliximab to its biosimilars
Knyazev O.V., Zvyaglova M.Y., Kagramanova A.V., Li I.A., Sabelnikova E.A., Lishchinskaya A.A., Kulakov D.S., Parfenov A.I.
The use of Tofacitinib in the treatment of inflammatory bowel disease
Nasonov E.L., Abdulganieva D.I., Fairushina I.F.
Use of mesenchymal stem cells in the combination therapy of ulcerative colitis
Knyazev O.V., Parfenov A.I., Konoplyannikov A.G., Boldyreva O.N.
Complete elimination of cytomegalovirus without antiviral therapy after systemic mesenchymal stromal cell transplantation in a patient with ulcerative colitis (a clinical case)
Kniazev O.V., Lazebnik L.B., Parfenov A.I., Ruchkina I.N., Shcherbakov P.L., Konopliannikov A.G., Mikhaĭlova Z.F., Khomeriki S.G.
Rebamipide: evidence base for use in gastroenterology
Andreev D.N., Maev I.V.
Celiac disease associated with ulcerative colitis
Krums L.M., Babaian A.F., Bykova S.V., Lishchinskaia A.A., Khomeriki S.G., Gudkova R.B., Sabel'nikova E.A., Kniazev O.V., Parfenov A.I.
Catalase gene rs1001179 polymorphism and oxidative stress in patients with chronic hepatitis C and ulcerative colitis
Bulatova I.A., Tret'iakova I.I., Shchekotov V.V., Shchekotova A.P., Ulitina P.V., Krivtsov A.V., Nenasheva O.I.
Pulmonary lesion in a female patient with hormone-dependent ulcerative colitis
Mikhaylova Z.F., Baryshnikov E.N., Ruchkina I.N., Tsvetkova O.A., Rogova E.F., Parfenov A.I., Mikhailova Z.F., Baryshnikov E.N., Ruchkina I.N., Tsvetkova O.A., Rogova E.F., Parfenov A.I.
Biomarkers of inflammatory bowel disease activity
Fadeeva N.A., Korneeva I.A., Knyazev O.V., Parfenov A.I.
Safety of mesenchymal stromal cell therapy for inflammatory bowel diseases: Results of a 5-year follow-up
Kniazev O.V., Parfenov A.I., Konopliannikov A.G., Ruchkina I.N., Churikova A.A., Bykova S.V., Albulova E.A., Boldyreva O.N., Fadeeva N.A., Lishchinskaia A.A.
Clinicopathogenetic variants of anemia in patients with intestinal inflammation
Drozdov V.N., Lishchinskaya A.A., Parfenov A.I., Noskova K.K., Ruchkina I.N., Varvanina G.G., Tkachenko E.V., Drozdov V.N., Lischinskaya A.A., Parfenov A.I., Noskova K.K., Ruchkina I.N., Varvanina G.G., Tkachenko E.V.
Adherence to therapy of patients with inflammatory bowel diseases
Parfenov A.I., Kagramanova A.V., Babayan A.F., Knyazev O.V.
Long-term results of medical treatment in patients with a severe attack of ulcerative colitis
Khalif I.L., Nanaeva B.A., Golovenko A.O., Golovenko O.V.
Use of melatonin in combined treatment for inflammatory bowel diseases
Rakhimova O.Y., Rakhimova O.Y.
Is histological remission of ulcerative colitis achievable?
Knyazev O.V., Kagramanova A.V., Khomeriki S.G., Parfenov A.I.
Vedolizumab in patients with inflammatory bowel diseases of in real clinical practice
Shapina M.V., Nanaeva B.A.
Value of adhesion molecules for evaluating the efficiency of therapy for ulcerative colitis and Crohn's disease
Parfenov A.I., Boldyreva O.N., Ruchkina I.N., Kniazev O.V., Sagynbaeva V.É., Shcherbakov P.L., Khomeriki S.G., Lazebnik L.B., Konopliannikov A.G.
Fecal excretion of short-chain fatty acids as a marker of the severity of ulcerative colitis
Kosacheva T.A., Sil'vestrova S.Y., Drozdov V.N., Kosacheva T.A., Silvestrova S.Y., Drozdov V.N.
1 - 37 of 37 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies